# Kyverna Therapeutics, Inc.: Form 8-K, filed Sep 16, 2024

- Company: [Kyverna Therapeutics, Inc.](/companies/kytx.md) (CIK 1994702)
- Form: 8-K
- Filed: 2024-09-16
- Accepted by EDGAR: Sep 16, 2024, 12:05 ET
- Period: 2024-09-13
- Accession: 0001213900-24-078736
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1994702/000121390024078736/ea0214607-8k_kyverna.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1994702/000121390024078736/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1994702/000121390024078736/ea0214607-8k_kyverna.htm

Filed Sep 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-078736. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.